Release Date: November 24, 2025

Expiration Date: November 24, 2026

Activity Overview

This on-demand virtual symposium brings together expert clinician-researchers to discuss the role of B-cell pathways in the pathophysiology of generalized myasthenia gravis and how this provides therapeutic targets and will potentially expand the array of novel therapies available for patients with this condition.

This educational activity is an archive of the live symposium held on October 31, 2025.

Target Audience

This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners, specialty physician assistants, nurses, and other health care providers involved in the care of patients with generalized myasthenia gravis.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Identify the role of B cells in the pathophysiology of gMG
Evaluate clinical data for current and emerging B cell–directed therapies for gMG
Develop treatment plans for patients with gMG

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Amgen.

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

GET STARTED WITH THIS PROGRAM:

Related Content